DPYD and colorectal cancer: Deenen et al. discussed the relationship between single nucleotide polymorphisms and haplotypes in the dihydropyrimidine dehydrogenase (DPD) gene, and the toxicity and efficacy of capecitabine in advanced colorectal cancer, indicating the potential of genetic biomarkers in predicting chemotherapy-related adverse events.